Yüklüyor......
Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study
OBJECTIVE: To determine the long-term safety and efficacy of repeated intrathecal (IT) administration of autologous mesenchymal stem cell-derived neural progenitors (MSC-NPs) in patients with progressive MS by evaluating subjects 2 years after treatment. METHODS: Twenty subjects were enrolled as par...
Kaydedildi:
| Yayımlandı: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Lippincott Williams & Wilkins
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7738177/ https://ncbi.nlm.nih.gov/pubmed/33277427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000928 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|